# Amrutanjan Health Care Ltd-$ (AMRUTANJAN)
> Exchange: NSE | Sector: Pharma | ISIN: INE098F01031

## Price
Current Price: ₹549.25
Day Change: -0.23%
52W High: ₹789.95
52W Low: ₹490
Market Cap: ₹1,613 Cr

## Valuation
P/E: 28.32
P/B: 4.36
EPS: ₹19.7
Book Value: ₹118.34
Dividend Yield: 0%

## Returns
1Y Return: -22.26%

## Profitability
ROE: 0%
ROCE: 27.12%
Debt/Equity: 0.01
Revenue Growth: 14.9%
Profit Growth: 1.1%
EBITDA Margin: 14.05%
Operating Margin: 16.69%

## About
Amrutanjan Health Care Ltd-$ is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Amrutanjan Health Care Ltd-$ makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Quarterly Report: Financial Results - Machine Readable Format
- Investor Presentation: Announcement under Regulation 30 (LODR)-Investor Presentation
- BSE Filing: Intimation On Rolling Out Of The Revised Second Phase 'ESOP 2' Of The Existing ESOP Scheme Of The Company By The Name Of 'Amrutanjan Health Care Limited - Employees Stock Option Scheme 2020'.

## Access
Current tier: anonymous
More history: Register free to see 7 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:00.503Z
Price History Updated: 2026-05-17T21:24:07.547Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:24:07.547Z
Quant Updated: 2026-05-17T21:24:07.547Z
Sentiment Updated: 2026-05-17T21:24:07.547Z
Financials Status: current
Financials Updated: 2026-05-18T17:32:07.933Z
Financials Last Attempt: 2026-05-18T17:32:07.933Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2007)
Revenue: ₹67 Cr
Operating Profit: ₹13 Cr (OPM 20%)
Net Profit: ₹6 Cr
Tax: ₹11 Cr

## Annual P&L History
Mar 2007: Rev ₹67Cr | PAT ₹6Cr | OPM 20%
Mar 2008: Rev ₹69Cr | PAT ₹6Cr | OPM 23%
Mar 2009: Rev ₹71Cr | PAT ₹5Cr | OPM 16%

## Balance Sheet (Mar 2007)
Total Assets: ₹37 Cr
Total Liabilities: ₹37 Cr
Borrowings: ₹6 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sambhu Prasad Sivalenka, Executive Chairman & MD
- N.  Swaminathan, Chief Financial Officer
- Gagan Preet Singh, Compliance Officer & Company Secretary
- R.  Narayanan, Chief Sales Officer
- Mani  Bhagavatheeswaran, Chief Marketing Officer

---
Source: rupiya.io/stocks/amrutanjan
Disclaimer: For research and education only. Not investment advice.